Valeo Pharma's market cap is currently ―. The company's EPS TTM is $-0.24; its P/E ratio is -0.56; Valeo Pharma is scheduled to report earnings on July 4, 2024, and the estimated EPS forecast is $-0.04. See an overview of income statement, balance sheet, and cash flow financials.

	Oct 23	Jul 23	Apr 23	Jan 23	Jul 22
Income Statement	-
Total Revenue	C$ 13.11M	C$ 14.08M	C$ 13.56M	C$ 13.16M	C$ 6.07M
Gross Profit	C$ 750.00K	C$ 4.21M	C$ 4.39M	C$ 3.73M	C$ 2.23M
EBIT	C$ -9.08M	C$ -2.38M	C$ -3.14M	C$ -2.99M	C$ -3.35M
EBITDA	C$ -8.32M	C$ -1.75M	C$ -2.51M	C$ -2.37M	C$ -3.10M
Net Income Common Stockholders	C$ -9.24M	C$ -5.84M	C$ -6.48M	C$ -6.25M	C$ -4.74M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	C$ 7.50M	C$ 9.78M	C$ 10.12M	C$ 10.95M	C$ 27.72M
Total Assets	C$ 41.21M	C$ 45.54M	C$ 48.36M	C$ 47.79M	C$ 66.91M
Total Debt	C$ 65.76M	C$ 62.79M	C$ 62.81M	C$ 61.87M	C$ 57.95M
Net Debt	C$ 58.26M	C$ 53.02M	C$ 52.69M	C$ 50.91M	C$ 30.23M
Total Liabilities	C$ 81.54M	C$ 80.58M	C$ 77.53M	C$ 71.36M	C$ 73.82M
Stockholders Equity	C$ -40.34M	C$ -35.05M	C$ -29.16M	C$ -23.57M	C$ -6.91M
Cash Flow	-
Free Cash Flow	-	C$ -1.37M	C$ -911.00K	C$ -11.27M	C$ -13.70M
Operating Cash Flow	C$ -2.67M	C$ -1.26M	C$ -674.00K	C$ -11.09M	C$ -2.14M
Investing Cash Flow	C$ -5.03M	C$ -111.00K	C$ -237.00K	C$ -176.00K	C$ -11.56M
Financing Cash Flow	C$ 5.05M	C$ 1.24M	C$ -57.00K	C$ -50.00K	C$ 36.36M

Currency in CAD

Valeo Pharma Earnings and Revenue History

Income Statement >

Valeo Pharma Debt to Assets

Balance Sheet >

Valeo Pharma Cash Flow

Cash Flow >

Valeo Pharma Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing